These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16773479)

  • 1. [Thrombocytopathy and blood complications in uremia].
    Hörl WH
    Wien Klin Wochenschr; 2006 Apr; 118(5-6):134-50. PubMed ID: 16773479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients.
    Ando M; Iwata A; Ozeki Y; Tsuchiya K; Akiba T; Nihei H
    Kidney Int; 2002 Nov; 62(5):1757-63. PubMed ID: 12371977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet dysfunction in renal failure.
    Boccardo P; Remuzzi G; Galbusera M
    Semin Thromb Hemost; 2004 Oct; 30(5):579-89. PubMed ID: 15497100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term therapy for uremic bleeding: effects of conjugate estrogens on the expression of platelet surface receptors for von Willebrand factor and fibrinogen (GPIb and GPIIb/IIIa glycoproteins).
    Salvati F; Liani M; Golato M
    Int J Artif Organs; 1997 Mar; 20(3):184-5. PubMed ID: 9151156
    [No Abstract]   [Full Text] [Related]  

  • 7. Uremic bleeding: pathogenesis and therapy.
    Weigert AL; Schafer AI
    Am J Med Sci; 1998 Aug; 316(2):94-104. PubMed ID: 9704663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimizing hemorrhagic complications in dialysis patients.
    Lohr JW; Schwab SJ
    J Am Soc Nephrol; 1991 Nov; 2(5):961-75. PubMed ID: 1760540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function in patients on maintenance hemodialysis: depressed or enhanced?
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G
    Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin.
    Małyszko JS; Małyszko J; Pawlak K; Pawlak D; Buczko W; Myśliwiec M
    Nephron; 2000 Apr; 84(4):305-11. PubMed ID: 10754406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of uremic bleeding.
    Couch P; Stumpf JL
    Clin Pharm; 1990 Sep; 9(9):673-81. PubMed ID: 2171866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.
    Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ
    Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of uremic platelet dysfunction].
    Ohzeki M; Fukushima T; Arakawa S; Ozeki M; Kosaka Y; Kobayashi S; Namikoshi T; Haruna Y; Sasaki T; Kashihara N
    Nihon Jinzo Gakkai Shi; 2005; 47(7):834-8. PubMed ID: 16296414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding diathesis is uremic patients treated with peritoneal dialysis: role of platelet glycoproteins GPIb and GPIIb/IIIa abnormalities.
    Liani M; Salvati F; Tresca E; Rubino L; De Meo F; Velussi C; Cahen R; Golato M
    Nephron; 1996; 74(1):234. PubMed ID: 8883056
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemostatic abnormalities in renal disease.
    Jubelirer SJ
    Am J Kidney Dis; 1985 May; 5(5):219-25. PubMed ID: 3923828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
    Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
    Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
    Jørgensen KA; Ingeberg S
    Nephron; 1979; 23(5):233-6. PubMed ID: 481658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced platelet apoptosis in chronic uremic patients.
    Li M; Wang Z; Ma T; Lu G; Yan R; Zhao L; Deng K; Dai K
    Ren Fail; 2014 Jul; 36(6):847-53. PubMed ID: 24655051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.